Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

15.20
Delayed Data
As of Jul 22
 -0.19 / -1.23%
Today’s Change
9.16
Today|||52-Week Range
17.55
-9.79%
Year-to-Date
Actelion (ALIOF) Beats Q2 Earnings & Revenues, View Up
Jul 22 / Zacks.com - Paid Partner Content
Baxter International (BAX) Q2 Earnings: What's in Store?
Jul 21 / Zacks.com - Paid Partner Content
Nutrisystem (NTRI) Q2 Earnings: What's in the Cards?
Jul 22 / Zacks.com - Paid Partner Content
Can CryoLife (CRY) Earnings Spring a Surprise in Q2?
Jul 21 / Zacks.com - Paid Partner Content
C.R. Bard (BCR) Well Poised to Beat Q2 Earnings Estimates?
Jul 21 / Zacks.com - Paid Partner Content
Aegerion to Withdraw Juxtapid from EU, Reduces Workforce
Jul 21 / Zacks.com - Paid Partner Content
Nektar Therapeutics (NKTR) Flagged As Strong On High Volume
Jul 21 / TheStreet.com - Paid Partner Content
Zafgen Halts Development of Beloranib, to Cut Jobs by ~34%
Jul 20 / Zacks.com - Paid Partner Content
Express Scripts (ESRX) Q2 Earnings: Stock to Disappoint?
Jul 21 / Zacks.com - Paid Partner Content
Valeant/Progenics Relistor Ok'd; FDA Panel Backs Brodalumab
Jul 20 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close15.39
Today’s open15.38
Day’s range15.17 - 15.47
Volume565,148
Average volume (3 months)1,003,959
Market cap$2.1B
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-45.24%
Earnings growth (this year)-52.93%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+14.99%
P/E ratioNM
Price/Sales9.67
Price/Book319.87

Competitors

 Today’s
change
Today’s
% change
EXELExelixis Inc+0.09+1.05%
INCRINC Research Holding...-0.16-0.37%
DBVTDBV Technologies SA+0.47+1.37%
LXRXLexicon Pharmaceutic...+0.34+2.21%
Data as of 3:59pm ET, 07/22/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$230.8M
Annual profit (last year)-$81.2M
Net profit margin-35.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts

Partner Offers

Search for Jobs